The reduction of tumor necrosis factor-alpha release and tissue damage by pentobarbital in the experimental endotoxemia model. 2007

Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan, Republic of China.

Sepsis is the leading cause of death for intensive care patients. Lipopolysaccharide (LPS) administration to animals under anesthesia is a strategy for the study of uncontrolled release of proinflammatory cytokines. Anesthetics have been indicated that they can specially affect immune responses, such as the inflammatory response. Pentobarbital is an anesthetic used mainly in animal studies. Thus, the effect of pentobarbital on tumor necrosis factor-alpha (TNF-alpha) release was determined. The results revealed that pentobarbital suppressed the expression of TNF-alpha mRNA and its proteins, which may result from the decrease in the activities of nuclear factor-kappaB and activator protein 1 and the reduction of the expression of p38 mitogen-activated protein kinase by pentobarbital. After the inhibitory activity of the pentobarbital for TNF-alpha release was proven in vivo, the cytotoxic effects of LPS were examined in vivo with or without pentobarbital treatments. In vivo results indicated that plasma levels of alanine aminotransferase, aspartate aminotransferase, lactic dehydrogenase, creatine kinase, serum urea nitrogen, and amylase decreased dramatically in the anesthetic group with pentobarbital administration. Finally, the effect of pentobarbital on TNF-alpha-related cell death was monitored in vitro, and the results indicated the pentobarbital could directly enhance the viabilities of cells under the treatment of TNF-alpha and protected cells from apoptosis induced by deferoxamine mesylate-induced hypoxia. These results suggest that pentobarbital significantly influences the LPS-induced inflammatory response and protects cells from death directly and indirectly induced by TNF-alpha. The information provides a perspective to re-evaluate the results of the experiments in which animals were anesthetized with pentobarbital. The anti-inflammatory effects of the drugs may have been caused by the synergistic effect of pentobarbital.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000777 Anesthetics Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. Anesthetic,Anesthetic Agents,Anesthetic Drugs,Anesthetic Effect,Anesthetic Effects,Agents, Anesthetic,Drugs, Anesthetic,Effect, Anesthetic,Effects, Anesthetic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
January 1995, Journal of clinical immunology,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
June 1999, Critical care medicine,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
June 1991, Journal of applied physiology (Bethesda, Md. : 1985),
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
October 1993, The Journal of infectious diseases,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
February 1993, The Journal of experimental medicine,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
January 1994, Journal of hepatology,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
September 1992, The Journal of clinical investigation,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
January 1995, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
November 2007, Translational research : the journal of laboratory and clinical medicine,
Fwu Lin Yang, and Chi Han Li, and Bang Gee Hsu, and Nu-Man Tsai, and Shinn Zong Lin, and Horng Jyh Harn, and Hsing I Chen, and Kuang Wen Liao, and Ru Ping Lee
June 1996, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!